Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-030835
Filing Date
2025-03-03
Accepted
2025-03-03 16:05:32
Documents
94
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bdsx-20241231.htm   iXBRL 10-K 3296846
2 EX-4.8 bdsx-ex4_8.htm EX-4.8 33806
3 EX-10.36 bdsx-ex10_36.htm EX-10.36 1159522
4 EX-19.1 bdsx-ex19_1.htm EX-19.1 107662
5 EX-23.1 bdsx-ex23_1.htm EX-23.1 2858
6 EX-31.1 bdsx-ex31_1.htm EX-31.1 16442
7 EX-31.2 bdsx-ex31_2.htm EX-31.2 16468
8 EX-32.1 bdsx-ex32_1.htm EX-32.1 8949
9 EX-32.2 bdsx-ex32_2.htm EX-32.2 8961
  Complete submission text file 0000950170-25-030835.txt   15208694

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bdsx-20241231.xsd EX-101.SCH 2159387
97 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20241231_htm.xml XML 2260719
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39659 | Film No.: 25697776
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)